Qube Research & Technologies LTD Merck & Co., Inc. Put Options Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $37.1 Million - $43.1 Million	334,200 Added 450.4%	408,400 $46.4 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $6.5 Million - $6.98 Million	-52,500 Reduced 41.44%	74,200 $9.19 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $18.3 Million - $21.3 Million	-161,200 Reduced 55.99%	126,700 $16.7 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $6.1 Million - $6.64 Million	60,900 Added 26.83%	287,900 $31.4 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $15.1 Million - $16.8 Million	147,100 Added 184.11%	227,000 $23.4 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $8.68 Million - $9.46 Million	79,900 New	79,900 $9.22 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.